Adialante
Adialante develops low-cost, clinical-grade MRI systems and related services for accessible cancer and neuroimaging screening.
Source: ycombinator.com
Latest round on record: Pre Seed, June 2026, amount undisclosed.
All 2 rounds ↓Signals
Website registeredNov 23, 2022 (4 years old)
Funding rounds
- Pre Seed · amount undisclosed
- Website created
- Date unknownRound · $500K*Source: ycombinator.com
Founders and team
ET
Efrain Torres CEO & Co-Foundersource: adialante.comPJ
Parker Jenkins COO & Co-Foundersource: adialante.com
Investors
Companies like Adialante
OOne Biosciences$17.43M Series A · Jul 2025
HHormona$7M Seed · May 2025CCHOSEN by DermatologySeries A · Oct 2026
NNeurode
BBiomarx$940K Pre Seed · Jan 2026SSimple HealthKit$8M Series A · Feb 2023
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/adialante (get a free API key).